The Indiana Horse Racing Commission (IHRC) unveiled their 2015 drug testing program at its public meeting on March 10.
A synopsis presented by IHRC executive director Joe Gorajec includes a new primary testing laboratory, a unique-to-the-industry audit laboratory, expanded out-of-competition testing, and cobalt testing. Several new elements in this year’s program are consistent with recommendations made by The Jockey Club in their much publicized 2014 McKinsey Report titled Raising the Standard of Testing and Enforcement.
Primary Laboratory—The Indiana Department of Administration has selected Truesdail Laboratory, in Tustin, California, as the IHRC’s primary laboratory. Truesdail is accredited by the Racing Medication and Testing Consortium and the lab’s contract will include performance-based metrics ensuring the quality of its testing and the timeliness of reporting.
Quality Assurance Program—The quality of Indiana’s testing will be further ensured by the addition of an audit laboratory, which will perform periodic testing. A number of samples will be simultaneously sent to this laboratory for quality assurance. The IHRC has committed up to $100,000 towards its audit program. Industrial Laboratory, in Denver, Colorado, will perform this audit function for the commission.
Out-of-Competition Testing—The IHRC will increase its target for out-of-competition testing to 500 horses for 2015. This increase represents a doubling of its historical average of annual out-of-competition tests. The new benchmark will raise Indiana’s out of compe